Cite
HARVARD Citation
Dalla Pietà, A. et al. (2021). Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cells. Journal for immunotherapy of cancer. 9 (7), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Dalla Pietà, A. et al. (2021). Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cells. Journal for immunotherapy of cancer. 9 (7), p. . [Online].